Where are you on your gen AI journey? This guide by CNET's experts will point you in the right direction. Jon Skillings is an ...

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...

Small molecules with big potential The two drugs used in this study are already approved to treat rare cancers. Tazemetostat, known under the brand name Tazverik, was approved by the U.S. FDA in ...

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.

2025 — Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts ... Mar. 27, 2025 — A research team has ...

You cannot treat diabetes on your own. Your doctor will help you make a diabetes treatment plan that is right for you. Toujeo is an injectable insulin medication for the treatment of diabetes ...

The move comes less than a week after Novo’s largest rival, American company Eli Lilly, announced successful clinical trial results for its new oral diabetes medication, which also had ...

Diabetes strikes 42 million in Canada and the US, can cannabis make a difference? The loss of Gossip Girl start Michelle Tractenberg has put diabetes in the national attention, Tractenberg ...

According to court documents, Eli Lilly accuses Empower Pharmacy of allegedly selling potentially dangerous versions of its drugs Mounjaro and Zepbound — two injectable medications containing ...

(Reuters) -A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal ...